As the newly appointed chief of the Division of Breast Surgery in the Department of Surgery, Veronica Jones, M.D., City of Hope continues to seek out the latest advancements...

Ken Hunt is the kind of corporate hired gun who specializes in showing companies how to operate more efficiently and increase their bottom line. A management consultant based in Chicago...

Deborah Harkness never stops teaching. A historian, the 58-year-old Harkness holds forth at the University of Southern California, captivating her students with insights on European history and the history of...

Could a new molecule targeting a protein called PCNA help scientists develop a cancer-stopping pill? New preclinical research suggests it may be possible. Researchers aimed at a protein once thought to...

It was August 2021, and Devonne Swift’s cough had persisted for two weeks. She was 53, a mom and a never-smoker. For over 30 years, she’d worked at the American...

Ida Yaghoobians was 51 years old and unconcerned about the blood she had been seeing in her stool for about a year — she had some hemorrhoids, so she chalked...

Imelda Moreno Jordan is a strong, energetic woman who can tackle almost any challenge. She’s not only the center of an all-male family — one husband and four boys —...

In a clinical trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer — findings...

The remarkable results of a new City of Hope study show that the natural botanical Andrographis paniculata, when given in conjunction with chemotherapy, may be a major breakthrough in...

Scientists at City of Hope, working in collaboration with researchers at Translational Genomics Research Institute (TGen), have found that the actions of circulating immune cells at the start of immunotherapy...